RT Journal Article
T1 Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism
A1 Galeano Valle, Francisco
A1 Oblitas, Christian-Mario
A1 Ferreiro Mazón, M.M.
A1 Alonso Muñoz, L.
A1 Toro Cervera, Jorge del
A1 Demelo Rodríguez, Pablo
AB COVID-19 pneumonia could be associated with an increased risk of venous thrombosis.Antiphospholipid antibodies might be involved in thrombosis in COVID-19 patients.Prevalence of antiphospholipid antibodies in COVID-19 and venous thrombosis was low.
PB Elservier
SN 0049-3848
YR 2020
FD 2020
LK https://hdl.handle.net/20.500.14352/129428
UL https://hdl.handle.net/20.500.14352/129428
LA eng
NO Galeano-Valle F, Oblitas CM, Ferreiro-Mazón MM, Alonso-Muñoz J, del-Toro-Cervera J, Demelo-Rodríguez P. Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism. Thromb Res. 2020;192:113-115. doi: 10.1016/j.thromres.2020.05.017. Epub 2020 May 15.
DS Docta Complutense
RD 25 feb 2026